Trading in ACADIA Pharma halted pending news

|About: ACADIA Pharmaceuticals... (ACAD)|By:, SA News Editor

Nasdaq halted trading in ACADIA Pharmaceuticals (NASDAQ:ACAD) at 7:00 am ET this morning pending news.

The Ad Comm review of NUPLAZID (pimavanserin) is today.

Previously: Ad Comm review of ACADIA Pharma's NUPLAZID tomorrow; shares up 15% premarket on optimism for positive vote (March 28)

Update: Ad Comm votes 12 - 2 in favor of approval.

Subscribe for full text news in your inbox

This was corrected on 03/29/2016 at 02:50 PM. Ad Comm backs approval.